Prolacta Bioscience

Biotechnology ResearchCalifornia, United States201-500 Employees

Prolacta Bioscience reduces premature infant complications and hospital costs with 100% human milk-based fortifiers and formulas. Trusted by more than 55% of Level 3&4 U.S. NICUs.

Prolacta has helped change the standard of care for more than 125,000 critically ill and premature infants, since introducing the world’s first and only 100% human milk-based fortifier. 

Our nutritional products have been evaluated in 30+ peer-reviewed clinical studies, demonstrating shorter NICU stays and better outcomes for premature infants born weighing <1250 g, compared to cow milk-based products. Extending the clinically proven benefits of human milk, Prolacta has developed Surgifort®, the first and only FDA-approved human milk-based fortifier designed for term infants recovering from corrective surgery for gastroschisis.

Learn how Prolacta’s Exclusive Human Milk Diet can improve outcomes and reduce total hospital costs. Visit Prolacta.com

Sign up for free to view info

Email Format Employee directory